R. Norman Harden MD's research while affiliated with Shirley Ryan AbilityLab and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publication (1)
This topical update reports recent progress in the international effort to develop a more accurate and valid diagnostic criteria for complex regional pain syndrome (CRPS). The diagnostic entity of CRPS (published in the International Association for the Study of Pain’s Taxonomy monograph in 1994; International Association for the Study of Pain [IAS...
Citations
... The inclusion criteria were as follows: (1) age 18-60 years; (2) patients diagnosed with CRPS type 1 or 2 of the lower extremities based on the criteria of Harden et al. (Budapest criteria) 17 ; (3) patients who had undergone LSGB at the L3 level twice before LSGN, followed by ≥ 50% pain relief; (4) patients with pain duration of ≤ 2 years after a painful event; (5) a baseline pain intensity score of ≥ 6 on the visual analogue scale (VAS, 0 = no pain, 10 = worst pain imaginable) after conservative treatment; and (6) patients in whom the affected extremity had a lower temperature (≥ 1 °C) than the unaffected side. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/279496369426440-1443648535451_Q64/Peter-Wilson-12.jpg)
